Mapping cancer’s genetic drivers: Sequencing, biomarkers and equity

Cancer genomics is transforming how we understand, detect, and treat tumors, but translating genetic insights into reliable, equitable clinical care depends on robust sequencing strategies, validated biomarkers, responsible data use, and fair patient access.